Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 14 | 14 |
| 1997 | 0 | 11 | 11 |
| 1998 | 0 | 15 | 15 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 15 | 15 |
| 2001 | 2 | 17 | 19 |
| 2002 | 1 | 14 | 15 |
| 2003 | 0 | 22 | 22 |
| 2004 | 0 | 20 | 20 |
| 2005 | 0 | 31 | 31 |
| 2006 | 0 | 21 | 21 |
| 2007 | 1 | 29 | 30 |
| 2008 | 0 | 41 | 41 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 38 | 38 |
| 2011 | 0 | 33 | 33 |
| 2012 | 0 | 25 | 25 |
| 2013 | 2 | 36 | 38 |
| 2014 | 0 | 32 | 32 |
| 2015 | 1 | 32 | 33 |
| 2016 | 0 | 54 | 54 |
| 2017 | 3 | 49 | 52 |
| 2018 | 3 | 44 | 47 |
| 2019 | 2 | 51 | 53 |
| 2020 | 0 | 36 | 36 |
| 2021 | 2 | 32 | 34 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 10 | 10 |
| 2024 | 0 | 18 | 18 |
| 2025 | 0 | 7 | 7 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Established and Emerging Therapies for High-Risk Neuroblastoma. Paediatr Drugs. 2026 Mar; 28(2):159-175.
-
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis. JCO Glob Oncol. 2026 Jan; 12:e2400435.
-
The Benefits of Exercise Training in Combination With Weight Loss Therapies. Diabetes. 2025 Dec 01; 74(12):2199-2206.
-
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD). J Affect Disord. 2025 Dec 01; 390:119836.
-
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases. J Am Coll Surg. 2025 Jul 01; 241(1):28-37.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy. Haematologica. 2025 Nov 01; 110(11):2635-2646.
-
Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2025 Jun; 72(6):e31673.
-
Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism. J Clin Endocrinol Metab. 2025 Feb 18; 110(3):e814-e826.
-
Long-Term Outcomes of Neoadjuvant Intraarterial Chemotherapy for Locally Invasive Lacrimal Gland Carcinoma ex Pleomorphic Adenoma. Ophthalmic Plast Reconstr Surg. 2025 Jul-Aug 01; 41(4):432-438.